Cargando…

Molecular mechanisms underlying hyperglycemia associated cognitive decline

Diabetes mellitus (DM) is a metabolic disease characterized by chronic hyperglycemia. DM can lead to a number of secondary complications affecting multiple organs in the body including the eyes, kidney, heart, and brain. The most common effect of hyperglycemia on the brain is cognitive decline. It h...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Mrinal, Pandey, Shivani, Rumman, Mohammad, Singh, Babita, Mahdi, Abbas Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800261/
https://www.ncbi.nlm.nih.gov/pubmed/36590246
http://dx.doi.org/10.1016/j.ibneur.2022.12.006
_version_ 1784861257600335872
author Gupta, Mrinal
Pandey, Shivani
Rumman, Mohammad
Singh, Babita
Mahdi, Abbas Ali
author_facet Gupta, Mrinal
Pandey, Shivani
Rumman, Mohammad
Singh, Babita
Mahdi, Abbas Ali
author_sort Gupta, Mrinal
collection PubMed
description Diabetes mellitus (DM) is a metabolic disease characterized by chronic hyperglycemia. DM can lead to a number of secondary complications affecting multiple organs in the body including the eyes, kidney, heart, and brain. The most common effect of hyperglycemia on the brain is cognitive decline. It has been estimated that 20–70% of people with DM have cognitive deficits. High blood sugar affects key brain areas involved in learning, memory, and spatial navigation, and the structural complexity of the brain has made it prone to a variety of pathological disorders, including T2DM. Studies have reported that cognitive decline can occur in people with diabetes, which could go undetected for several years. Moreover, studies on brain imaging suggest extensive effects on different brain regions in patients with T2D. It remains unclear whether diabetes-associated cognitive decline is a consequence of hyperglycemia or a complication that co-occurs with T2D. The exact mechanism underlying cognitive impairment in diabetes is complex; however, impaired glucose metabolism and abnormal insulin function are thought to play important roles. In this review, we have tried to summarize the effect of hyperglycemia on the brain structure and functions, along with the potential mechanisms underlying T2DM-associated cognitive decline.
format Online
Article
Text
id pubmed-9800261
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-98002612022-12-31 Molecular mechanisms underlying hyperglycemia associated cognitive decline Gupta, Mrinal Pandey, Shivani Rumman, Mohammad Singh, Babita Mahdi, Abbas Ali IBRO Neurosci Rep Review Article Diabetes mellitus (DM) is a metabolic disease characterized by chronic hyperglycemia. DM can lead to a number of secondary complications affecting multiple organs in the body including the eyes, kidney, heart, and brain. The most common effect of hyperglycemia on the brain is cognitive decline. It has been estimated that 20–70% of people with DM have cognitive deficits. High blood sugar affects key brain areas involved in learning, memory, and spatial navigation, and the structural complexity of the brain has made it prone to a variety of pathological disorders, including T2DM. Studies have reported that cognitive decline can occur in people with diabetes, which could go undetected for several years. Moreover, studies on brain imaging suggest extensive effects on different brain regions in patients with T2D. It remains unclear whether diabetes-associated cognitive decline is a consequence of hyperglycemia or a complication that co-occurs with T2D. The exact mechanism underlying cognitive impairment in diabetes is complex; however, impaired glucose metabolism and abnormal insulin function are thought to play important roles. In this review, we have tried to summarize the effect of hyperglycemia on the brain structure and functions, along with the potential mechanisms underlying T2DM-associated cognitive decline. Elsevier 2022-12-13 /pmc/articles/PMC9800261/ /pubmed/36590246 http://dx.doi.org/10.1016/j.ibneur.2022.12.006 Text en © 2022 Published by Elsevier Ltd on behalf of International Brain Research Organization. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review Article
Gupta, Mrinal
Pandey, Shivani
Rumman, Mohammad
Singh, Babita
Mahdi, Abbas Ali
Molecular mechanisms underlying hyperglycemia associated cognitive decline
title Molecular mechanisms underlying hyperglycemia associated cognitive decline
title_full Molecular mechanisms underlying hyperglycemia associated cognitive decline
title_fullStr Molecular mechanisms underlying hyperglycemia associated cognitive decline
title_full_unstemmed Molecular mechanisms underlying hyperglycemia associated cognitive decline
title_short Molecular mechanisms underlying hyperglycemia associated cognitive decline
title_sort molecular mechanisms underlying hyperglycemia associated cognitive decline
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800261/
https://www.ncbi.nlm.nih.gov/pubmed/36590246
http://dx.doi.org/10.1016/j.ibneur.2022.12.006
work_keys_str_mv AT guptamrinal molecularmechanismsunderlyinghyperglycemiaassociatedcognitivedecline
AT pandeyshivani molecularmechanismsunderlyinghyperglycemiaassociatedcognitivedecline
AT rummanmohammad molecularmechanismsunderlyinghyperglycemiaassociatedcognitivedecline
AT singhbabita molecularmechanismsunderlyinghyperglycemiaassociatedcognitivedecline
AT mahdiabbasali molecularmechanismsunderlyinghyperglycemiaassociatedcognitivedecline